The DOI matches its Crossref record; 45 of the 48 references it cites were found in a registry or an index; 17 of the 57 sources its claims cite were checked for support.
Intolerance-of-uncertainty therapy versus metacognitive therapy for generalized anxiety disorder in primary health care: A randomized controlled pilot trial
Open accessAbstract
Objective This randomized controlled pilot study investigated the feasibility of a future full-scale RCT to compare the effects of intolerance-of-uncertainty therapy (IUT) and metacognitive therapy (MCT) in primary health care patients with generalized anxiety disorder (GAD). Preliminary treatment effects were also evaluated. Materials and methods 64 patients with GAD at a large primary health care center in Stockholm, Sweden, were randomized to IUT or MCT. Feasibility outcomes included participant recruitment and retention, willingness to receive psychological treatment, and therapists' competence in and adherence to treatment protocols. Self-reported scales were used to assess treatment outcomes, including worry, depression, functional impairment, and quality of life. Results Recruitment was satisfactory, and dropout was low. On a scale from 0 to 6, participants were satisfied with participating in the study (M = 5.17, SD = 1.09). Following brief training, therapists' competence was rated as moderate, and adherence was rated as weak to moderate. From pre- to post-treatment, reductions on the primary treatment outcome measure of worry were of a large effect size and statistically significant in both the IUT and MCT conditions (Cohen's d for IUT = -2.69, 95% confidence interval [-3.63, -1.76] and d for MCT = -3.78 [-4.68, -2.90]). The between-group effect size from pre- to post-treatment was large and statistically significant (d = -2.03 [-3.31, -0.75]), in favor of the MCT condition. Conclusion It is feasible to carry out a full-scale RCT to compare the effects of IUT to MCT for patients with GAD in primary health care. Both protocols seem effective, and MCT seems superior to IUT, but a full-scale RCT is needed to confirm these conclusions. © 2023 af Winklerfelt Hammarberg et al.
Overview
CoChat Summary
## TL;DR
This randomized controlled pilot trial found that a future full-scale RCT comparing intolerance-of-uncertainty therapy (IUT) and metacognitive therapy (MCT) for generalized anxiety disorder in primary care is feasible. Both treatments improved outcomes, but MCT showed larger pre- to post-treatment gains in worry and several secondary outcomes.
## Key findings
- Feasibility looked good: Of 69 eligible patients, 64 consented and were randomized; recruitment averaged 4.6 (SD 2.7) patients/month, dropout was 10.9%, and participants’ overall satisfaction with participation was M = 5.17/6 (SD 1.09).
- Therapist ratings were mixed: After brief training, IUT therapists’ competence was rated 2.9/6 (SD 0.4) and MCT therapists’ competence 2.6/5 (SD 0.4), while adherence was 2.7/4 (SD 0.4) for IUT and 1.9/4 (SD 0.3) for MCT; MCT adherence was significantly lower.
- Worry improved in both groups, with larger gains for MCT: From pre- to post-treatment, worry reductions were large and significant in both groups (IUT d = -2.69, 95% CI [-3.63, -1.76]; MCT d = -3.78, [-4.68, -2.90]), and the between-group effect favored MCT (d = -2.03, [-3.31, -0.75]).
- Other outcomes also generally favored MCT: MCT produced larger reductions in depressive symptoms and functional impairment and improved quality of life; at post-treatment, 71.9% of IUT vs 96.3% of MCT participants showed reliable improvement on worry, and recovery rates were higher for MCT using both PSWQ cutoffs (47-point cutoff: 59.3% vs 18.8%; 53-point cutoff: 81.5% vs 37.5%).
## Methods
- Randomized controlled pilot trial in 64 primary care patients with primary GAD at Liljeholmen Primary Health Care Center in Stockholm, Sweden, conducted 2018–2020; participants were randomized 1:1 to IUT or MCT.
- Both interventions were individual, protocol-based CBT treatments delivered for up to 12 sessions, with therapists drawn from the primary care center and given brief training plus biweekly supervision.
- Feasibility was assessed via recruitment, retention, satisfaction, willingness to receive psychological treatment, and therapist competence/adherence; outcomes were analyzed with multilevel modeling on an intention-to-treat basis, plus Fisher’s exact tests for reliable change/recovery.
## Limitations
- The paper states that only one large primary health care center in an urban area participated, which limits generalizability.
- The authors note no inactive control group, so no conclusive causal inferences can be made about the treatment effects.
- Therapists were not randomized to treatment conditions but chose which therapy to deliver, so prior interest/competence could have biased findings.
- Evidence from the text also shows additional limitations: no sample size calculation was conducted, and therapist competence/adherence was assessed for only a small proportion of sessions with inter-rater reliability not ascertained.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 19 Not checked · 99 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Previous research shows that GAD often goes undetected and thus untreated in primary health care patients [6, 8, 11, 12, 16].”
§ Intolerance-of-uncertainty therapy versus metacognitive therapy for generalized anxiety disorder in primary health care: A randomized controlled pilot trial > Introduction Across the world, primary health care is the setting where most people with common mental disorders receive diagnosis and treatment [1–3]. Generalized anxiety disorder (GAD) is one of the most common anxiety disorders in primary health care patients [4, 5]. Lifetime prevalence varies across the world, but approximately 5% of the population of European and North American countries meet the criteria for the disorder at some point during their lives [4, 6, 7]. GAD is characterized by excessive and uncontrollable worry in several domains of daily life, as well as other symptoms, including irritability, restlessness, difficulty concentrating, fatigue, muscle tension, and sleep disturbance [8, 9]. To receive a diagnosis of GAD, these symptoms should have been present most days and affected functioning for at least six months [9]. Persistent anxiety and inability to control worry are often associated with muscle tension, which can cause chronic pain and dizziness [10, 11]. GAD is also associated with other somatic health problems, including irritable bowel syndrome and medically unexplained symptoms [8, 11–13] Moreover, it can increase the risk of other mental health problems, such as sleep disorders, adjustment disorders, and depression [8, 14]. These health problems often motivate patients with GAD to frequently attend primary health care for somatic and psychiatric complaints [12, 15], which in turn may lead to extensive physical examinations and investigations [10, 11]. Previous research shows that GAD often goes undetected and thus untreated in primary health care patients [6, 8, 11, 12, 16]. Accordingly, the disorder leads to disability and suffering for these patients, as well as high costs for society [8, 17, 18]. Cognitive behavioral therapy (CBT) is an effective treatment for several anxiety disorders [19, 20]. However, in contrast to the guidelines for treating other anxiety disorders, guidelines for GAD recommend antidepressant medication as the first-hand treatment and CBT as a secondary choice [21, 22]. In primary health care, treatment for GAD thus consists mainly of prescribing antidepressants, such as selective serotonin reuptake inhibitors, and primary health care patients with GAD have limited access to CBT [6, 11].
What the sources say
- Not checked — no full text of the sourcecites [6] EA Hoge, 2012, Generalized anxiety disorder: diagnosis and treatment, Bmj source
- Not checked — no full text of the sourcecites [8] J DeMartini, 2019, Generalized Anxiety Disorder, Annals of internal medicine source
- Not matchedcites [11] PP Roy-Byrne, 2004, Primary care perspectives on generalized anxiety disorder, The Journal of clinical psychiatry
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not checked — no full text of the sourcecites [12] H Parmentier, 2013, Comprehensive review of generalized anxiety disorder in primary care in Europe., Curr Med Res Opin source
- Partly supportedcites [16] P Roberge, 2015, Generalized anxiety disorder in primary care: mental health services use and treatment adequacy., BMC family practice sourceExperimental — accuracy not yet measured
The Background reports low rates of GAD recognition in primary care, and the Results > Indicators of care say only 52.5% of participants had been identified as having GAD in the past year. The paper also links detection to treatment adequacy, but it does not show that undetected patients were therefore untreated: many participants received medication or counselling, even when treatment did not meet its adequacy criteria. No page numbers are provided in our copy. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“At least two studies have found that in patients with GAD, MCT reduces worry better than other CBT protocols [31, 32].”
§ Intolerance-of-uncertainty therapy versus metacognitive therapy for generalized anxiety disorder in primary health care: A randomized controlled pilot trial > Introduction Across the world, primary health care is the setting where most people with common mental disorders receive diagnosis and treatment [1–3]. Generalized anxiety disorder (GAD) is one of the most common anxiety disorders in primary health care patients [4, 5]. Lifetime prevalence varies across the world, but approximately 5% of the population of European and North American countries meet the criteria for the disorder at some point during their lives [4, 6, 7]. GAD is characterized by excessive and uncontrollable worry in several domains of daily life, as well as other symptoms, including irritability, restlessness, difficulty concentrating, fatigue, muscle tension, and sleep disturbance [8, 9]. To receive a diagnosis of GAD, these symptoms should have been present most days and affected functioning for at least six months [9]. Persistent anxiety and inability to control worry are often associated with muscle tension, which can cause chronic pain and dizziness [10, 11]. GAD is also associated with other somatic health problems, including irritable bowel syndrome and medically unexplained symptoms [8, 11–13] Moreover, it can increase the risk of other mental health problems, such as sleep disorders, adjustment disorders, and depression [8, 14]. These health problems often motivate patients with GAD to frequently attend primary health care for somatic and psychiatric complaints [12, 15], which in turn may lead to extensive physical examinations and investigations [10, 11]. Previous research shows that GAD often goes undetected and thus untreated in primary health care patients [6, 8, 11, 12, 16]. Accordingly, the disorder leads to disability and suffering for these patients, as well as high costs for society [8, 17, 18]. Cognitive behavioral therapy (CBT) is an effective treatment for several anxiety disorders [19, 20]. However, in contrast to the guidelines for treating other anxiety disorders, guidelines for GAD recommend antidepressant medication as the first-hand treatment and CBT as a secondary choice [21, 22]. In primary health care, treatment for GAD thus consists mainly of prescribing antidepressants, such as selective serotonin reuptake inhibitors, and primary health care patients with GAD have limited access to CBT [6, 11].
What the sources say
- Supportedcites [31] HM Nordahl, 2018, Metacognitive therapy versus cognitive-behavioural therapy in adults with generalised anxiety disorder., BJPsych Open source
The Discussion reports that MCT reduced worry more than CBT at post-treatment in patients with GAD. This paper supports one of the studies cited for the sentence; it does not need to establish the two-study count on its own. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [32] C van der Heiden, 2012, Randomized controlled trial on the effectiveness of metacognitive therapy and intolerance-of-uncertainty therapy for generalized anxiety disorder., Behav Res Ther source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“From pre- to post-treatment, reductions on the primary treatment outcome measure of worry were of a large effect size and statistically significant in both the IUT and MCT conditions (Cohen’s d for IUT = -2.69, 95% confidence interval [-3.63, -1.76] and d for MCT = -3.78 [-4.68, -2.90]).”
§ Intolerance-of-uncertainty therapy versus metacognitive therapy for generalized anxiety disorder in primary health care: A randomized controlled pilot trial > Abstract > Results
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Following brief training, therapists’ competence was rated as moderate, and adherence was rated as weak to moderate.”
§ Intolerance-of-uncertainty therapy versus metacognitive therapy for generalized anxiety disorder in primary health care: A randomized controlled pilot trial > Abstract > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Following brief training, therapists’ competence was rated as moderate, and adherence was rated as weak to moderate.”
§ Intolerance-of-uncertainty therapy versus metacognitive therapy for generalized anxiety disorder in primary health care: A randomized controlled pilot trial > Abstract > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
59 more claims
Create a free account to see all 133 claims and to verify the 2 references still open.
- Probably not a substantial claim. 37
- It may state two separate claims as one. 39
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910 · cited 3×
“Severity of depressive symptoms was assessed with the 9-item Patient Health Questionnaire (PHQ-9) [41].”
MethodInfluentialThe satisfaction with life scale
Diener, E., Emmons, R. A., Larsen, R. J., & Griffin, S. (1985) · Journal of Personality Assessment · doi:10.1207/s15327752jpa4901_13 · Cited by 31,768 · cited 3×
“Between pre-treatment and post-treatment, MCT resulted in a significant improvement in quality of life as measured by the SWLS (F(55) = 13.01, p = .001), whereas IUT did not (F(63.84) = 1.58, p = .213) (Table 3).”
MethodInfluential(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
(1998) · PubMed · Cited by 10,216
Jacobson, N. S., & Truax, P. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.1.12 · Cited by 7,770 · cited 1×
“Treatment response was assessed with the reliable change index [46], which was calculated using the internal consistency [47] of the PSWQ and the sample SD of this measure at pretreatment.”
MethodDevelopment and validation of the Penn State Worry Questionnaire
Meyer, T. J., Miller, M. L., Metzger, R. L., & Borkovec, T. D. (1990) · Behaviour Research and Therapy · doi:10.1016/0005-7967(90)90135-6 · Cited by 5,099
Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection
Kroenke, K., Spitzer, R. L., Williams, J. B. W., Monahan, P. O., & Löwe, B. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00004 · Cited by 4,741
Eldridge, S. M., Lancaster, G. A., Campbell, M. J., Thabane, L., Hopewell, S., Coleman, C. L., & Bond, C. M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150205 · Cited by 1,581 · cited 1×
“There are therefore several uncertainties about the feasibility of performing a full-scale RCT designed to compare the effectiveness of the two protocols for patients with GAD in primary health care, including recruiting and retaining participants [34].”
BackgroundDiener, E. (2011) · PsycTESTS Dataset · doi:10.1037/t01069-000 · Cited by 1,184
Research works printed but not linked: 5
- 2018, World Health Organisation. Integration of mental health into primary health care
- World Health Organisation, 2018, MENTAL HEALTH IN PRIMARY CARE: ILLUSION OR INCLUSION?
- World Health Organisation, 2017, Depression and Other Common Mental Disorders: Global Health Estimates
- National Board of Health and Welfare, National Guidelines for depression and anxiety
- H Nordahl, 2009, Metacognitive Therapy Competency Scale (MCT-CS)., Manchester: Metacognitive Therapy Institute (Upublisert).
Cited by
Wilson, E., Abbott, M. J., Norton, A. R., Berle, D., & Rapee, R. M. (2025) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2025.2478246 · Cited by 10
“…therapy yielded a significantly greater reduction in worry and depression at post-treatment when compared to CBT-IU (van der Heiden et al., 2012; Winklerfelt Hammarberg et al., 2023). van der Heiden et al. (2012) also found that metacognitive therapy demonstrated a significantly greater…”
Dai, X., Zhang, Z., Sun, L., Zhu, S., Wu, Y., Lian, J., & Deng, X. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.05.010 · Cited by 5
Chen, Y., Niu, X., Liao, H., & Wang, J. (2025) · British Journal of Developmental Psychology · doi:10.1111/bjdp.70017 · Cited by 2
Borthwick, C., Norton, A., Trenoska Basile, V., & Wootton, B. (2026) · British Journal of Clinical Psychology · doi:10.1111/bjc.70089
Gústavsson, S. M. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009090940.015
Metadata
- Authors
- af Winklerfelt Hammarberg, S., Toth-Pal, E., Jansson-Fröjmark, M., Lundgren, T., Westman, J., & Bohman, B.
- Affiliations
- Region Stockholm (SE)
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2023-06-14
- Volume
- 18
- Issue
- 6
- Pages
- e0287171
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC10266649
- OpenAlex
- W4380627995
- Cited by
- 9
- References
- 48
- Citations by year
- 2026: 3 · 2025: 5 · 2023: 1
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Stockholms Läns Landsting (20170770, 20180792)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Assessments
- Keywords
- metacognitive therapy, generalized anxiety disorder, primary care, feasibility, medication adherence, therapist competence, worry, depression, quality of life, functional disability
- MeSH terms
- Anxiety Disorders, Humans, Pilot Projects, Primary Health Care, Quality of Life, Uncertainty
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intolerance-of-uncertainty therapy versus metacognitive therapy for generalized anxiety disorder in primary health care: A randomized controlled pilot trial. https://app.cochat.ai/papers/10.1371/journal.pone.0287171
- The paper
- af Winklerfelt Hammarberg, S., Toth-Pal, E., Jansson-Fröjmark, M., Lundgren, T., Westman, J., & Bohman, B. (2023). Intolerance-of-uncertainty therapy versus metacognitive therapy for generalized anxiety disorder in primary health care: A randomized controlled pilot trial. PLoS ONE. https://doi.org/10.1371/journal.pone.0287171
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
